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Membrane rafts are small (10–200nm) sterol- and sphingolipid-enriched domains that compartmentalize cellular processes.
Membraneraftsplayanimportantroleinviralinfectioncyclesandviralvirulence.Virusesaredividedintofourmainclasses,enve-
loped DNA virus, enveloped RNA virus, nonenveloped DNA virus, and nonenveloped RNA virus. General virus infection cycle is
also classiﬁed into two sections, the early stage (entry process) and the late stage (assembly, budding, and release processes of virus
particles).Intheviralcycle,membraneraftsactasascaﬀoldofmanycellularsignaltransductions,whichareassociatedwithsymp-
toms caused by viral infections. In this paper, we describe the functions of membrane rafts in viral lifecycles and host cellular res-
ponse according to each virus classiﬁcation, each stage of the virus lifecycle, and each virus-induced signal transduction.
1.Introduction
Relationships between virus infection mechanisms and lipid
rafts had often been studied in complexes with caveolae [1,
2]. Lipid rafts, membrane microdomains enriched in choles-
terol, and sphingolipids represented by GM1 and globotriao-
sylceramide (Gb3Cer) were deﬁned at the Keystone Sympo-
sium on Lipid Rafts and Cell Function (March 23–28, 2006
in Steamboat Springs, CO) as follows: “Membrane rafts are
small (10–200nm), heterogeneous, highly dynamic, sterol-
and sphingolipid-enriched domains that compartmentalize
cellular processes. Small rafts can sometimes be stabilized to
form larger platforms through protein-protein and protein-
lipid interactions.” This deﬁnition led to the term “lipid raft”
being discarded in favor of the term “membrane raft”. The
term “membrane raft” underlies the concept that both pro-
teins and lipids, rather than solely lipid-driven interactions,
play an important role in the formation of these membrane
microdomains. The caveola, a cholesterol/sphingolipid-rich
small pit, depression, or invagination, is a site on the cell
surface that provides a platform for proteins and lipids to
interact and transmit signals. In the symposium, the range
of 10–200nm, which was adopted as the size of membrane
rafts, included the upper limit on the surface of a caveola.
Here, membrane rafts include caveolae [3].
Membrane rafts have been shown to be involved in the
virus entry, assembly, or/and budding process in infection
lifecycles of various viruses, such as retroviruses (Retroviri-
dae), RNA viruses (Arenaviridae, Astroviridae, Bunyaviri-
dae, Caliciviridae, Coronaviridae, Filoviridae, Flaviviridae,
Orthomyxoviridae, Paramyxoviridae, Picornaviridae, Reoviri-
dae,Rhabdoviridae,andTogaviridae),andDNAviruses(Ade-
noviridae, Hepadnaviridae, Herpesviridae, Papovaviridae,
Parvoviridae,andPoxviridae).Thesestudieshavedemonstra-
ted the localization of viral structural proteins in membrane
rafts and the eﬀects of raft-disrupting agents, which mainly
remove cholesterol from the surface membrane or inhibit
the synthesis of cholesterol, on the infection and replication
processes of these viruses. The virus infection process begins
with attachment of the virus to speciﬁc receptors on host
cell surfaces. Some RNA viruses, such as Orthomyxoviridae,
Rhabdoviridae and Togaviridae family viruses, and DNA
viruses, such as Adenoviridae and Papovaviridae family viru-
ses, enter cells through an endocytic pathway and inject viral
proteins and genes directly into the cytoplasm by fusion of
the viral envelope with the host cellular membrane or des-2 Biochemistry Research International
truction of viral capsids. Other enveloped viruses, such as
Paramyxoviridae family viruses, allow the viral membrane to
fuse directly with the host cell surface membrane and inject
theviralproteinsandgenesdirectlyintothecytoplasm.Tran-
scription and replication of DNA viruses except poxviruses
generally proceed inside the nucleus, whereas those of RNA
viruses except inﬂuenza virus proceed in the cytoplasm.
Newly synthesized progeny viral components are transfer-
red to organelles or the plasma membrane, resulting in for-
mation of progeny virus particles by assembly and/or bud-
ding. Virus particles are classiﬁed by conﬁguration of the
viral outer envelope into two types, enveloped viruses
(Arenaviridae, Bunyaviridae, Coronaviridae, Filoviridae, Fla-
viviridae, Herpesviridae, Hepadnaviridae, Orthomyxoviridae,
Paramyxoviridae Poxviridae, Rhabdoviridae and Togaviridae)
and nonenveloped viruses (Adenoviridae, Astroviridae, Cali-
civiridae, Picornaviridae, Papovaviridae, Parvoviridae and
Reoviridae) (Figures 1 and 2). The envelope constructs of
enveloped viruses are lipid bilayers derived from the host
cellular membrane of the cell surface, Golgi body, or endo-
plasmic reticulum (ER), where the viruses are budded. Viral
surface proteins transferred to the cell surface are buried in
the viral envelope together with the lipid bilayer of the host
cell surface (Figure 1). Nonenveloped viruses are generally
assembled in the cytoplasm or nucleus and burst into the
extracellular environment through membrane destruction
from cell death (Figure 2). In this paper, recent ﬁndings on
the function of membrane rafts in viral lifecycles and host
cellular response are discussed.
2. Role of Membrane Rafts in VirusEntry
The involvement of membrane rafts in virus entry has been
evaluated by the eﬀects of raft-disrupting reagents on virus
infection and by the eﬀects of cholesterol-removing reagents
such as methyl-β-cyclodextrin and cholesterol synthesis
inhibitors such as nystatin. Inhibition of virus infection by
cholesteroldepletionisgenerallyrecoveredbytheadditionof
exogenous cholesterol without aﬀecting virus binding to cel-
lular receptors. Traditional examinations of membrane raft
function in virus entry have been performed by biochemical
methods for detection of viral proteins and viral cellular
receptors within a detergent-insoluble fraction after virus
attachment and during virus infection or colocalization of
theseproteinsandreceptorswithspeciﬁcraftmarkerssuchas
caveolin-1, ﬂotillin, and GM1. Molecular biological exami-
nationsoftheroleofacaveola-dependentendocyticpathway
in virus entry have also been performed by inhibition
of caveola formation using RNA interference (RNAi) and
dominant-negative protein expression for normal caveolin-
1 knockdown.
3.EntryofEnvelopedViruses
Entry processes of enveloped viruses associated with mem-
brane rafts have been evaluated for lymphocytic choriome-
ningitis virus (LCMV; Arenaviridae)[ 4], coronaviruses in-
cluding severe acute respiratory syndrome coronavirus
(SARS-CoV) (Coronaviridae)[ 5–11], Ebola virus (Filoviri-
dae)[ 12–14], Marburg virus (Filoviridae)[ 12, 15], West Nile
virus (WNV; Flaviviridae)[ 16], dengue virus (DEN; Fla-
viviridae)[ 17–20], Japanese encephalitis virus (JEV; Flavivi-
ridae)[ 19, 21], human hepatitis C virus (HCV; Flaviviridae)
[22, 23], Epstein-Barr virus (EBV; herpesviridae)[ 24, 25],
herpes simplex virus-1 (HSV-1; herpesviridae)[ 26, 27]
including porcine herpesvirus-1 pseudorabies virus [28],
human herpesvirus-6 (HHV-6; Herpesviridae)[ 29], human
herpesvirus-8 of Kaposi’s sarcoma-associated herpesvirus
(HHV-8; Herpesviridae)[ 30, 31], inﬂuenza virus (Ortho-
myxoviridae)[ 32–37], vaccinia virus (Poxviridae)[ 38],
human immunodeﬁciency virus (HIV; Retroviridae)[ 39–
45], human T lymphotropic virus 1 (HTLV-1; Retroviridae)
[46, 47], Semliki Forest virus (Togaviridae)[ 48–51], and
Sindbis virus (Togaviridae)[ 51, 52].
The majority of enveloped viruses release viral internal
genomes and proteins into the intracellular compartment
through fusion processes induced by viral surface proteins
between viral and cellular membranes immediately after
virus attachment to receptors or the endocytic pathway.
Human coronavirus, a pathogen causing 10–30% of all
common colds manifesting upper respiratory and gastroin-
testinal symptoms, enters cells through caveola-dependent
endocytosis after attachment to the viral receptor CD13
within membrane rafts. It has been shown that virus infec-
tion is inhibited by caveola destruction using a cholesterol-
removing reagent and an RNAi method for caveolin-1 [5].
Mousehepatitisvirus(MHV)ofmurinecoronavirusesbinds
to nonraft membranes but moves to raft membranes for
virus entry and fusion processes. Membrane rafts are not
incorporated into the MHV virion and are not associated
with the spike (S) protein of MHV on the Golgi body mem-
brane,whichisthesiteofvirusassemblyandbudding.Mem-
brane rafts are therefore not required for the virus release
process [6, 7]. SARS-CoV, the most extensively researched
human coronavirus that causes severe acute respiratory syn-
drome (SARS), associates with membrane rafts as an entry
platform via the viral spike (S) protein after binding to
the viral receptor angiotensin-converting enzyme 2 (ACE2)
within rafts of Vero E6 cells [8, 10]. Moreover, SARS-CoV
and feline infectious peritonitis virus (FIPV), a coronavirus
causing lethal chronic disease in cats, enter cells through
a clathrin-independent and caveola-independent pathway
because both dominant-negative protein expressions of
Eps15 (required for the clathrin-dependent pathway) and
c a v e o l i n - 1h a v en oe ﬀect on virus infectivity and no colocal-
ization of caveolin-1 is observed with viral proteins during
virus entry. However, inhibition of virus infection by choles-
terol depletion indicates the importance of raft-mediated
endocytosis for the entry process of these viruses [9, 11].
Taken together, results of studies indicate that raft-mediated
endocytosis associated with cholesterol is distinctly diﬀerent
from caveolin-1-dependent endocytosis.
Ebola virus and Marburg virus, two of the most patho-
genic viruses in humans and nonhuman primates that cause
severe hemorrhagic fever with mortality rates reaching 90%,
enter host cells through folate receptor-α (FRα)a sav i r a l
coreceptor, which is a glycosyl phosphatidylinositol-(GPI-)Biochemistry Research International 3
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Figure 1: Entry, assembly, and budding processes of enveloped viruses. Some enveloped viruses, such as Orthomyxoviridae, Rhabdoviridae,
and Togaviridae family viruses, are incorporated into cells through an endocytic pathway. Other enveloped viruses, such as Paramyxoviridae
familyviruses,areincorporatedintocellsthroughdirectfusionbetweentheviralmembraneandcellsurfacemembrane.Herpesviridaefamily
virusesutilizebothpathways.ViralgenomesofenvelopedRNAviruses,suchasOrthomyxoviridaefamilyviruses,andenvelopedDNAviruses,
such as Herpesviridae family viruses, are replicated and transcribed in the nucleus. On the other hand, viral genomes of enveloped RNA
viruses,suchasParamyxoviridaefamilyviruses,arereplicatedandtranscribedinthecytoplasm.Afterassemblyofviralproteinsandgenomes,
progeny viruses are budded and then released from the cell surface membrane.
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Figure 2: Entry, assembly, and budding processes of nonenveloped viruses. Nonenveloped DNA viruses, such as Adenoviridae and
Papovaviridae family viruses, are incorporated into cells through endocytosis and then their viral DNA genomes are released into the cytop-
lasm by viral capsid destruction. Viral genomes are subjected to replication and transcription in the nucleus. After assembly of viral proteins
and genomes, progeny viruses are released from cells.4 Biochemistry Research International
anchored protein within membrane rafts [53]. The severe
pathogenesis of these viruses in humans makes studies on
the infection mechanism diﬃcult to perform using intact
viruses. Results of studies using pseudotypes possessing
these viral proteins suggest that ﬁloviruses utilize acidiﬁed
endosomes for vial entry [54, 55]. Inhibitory eﬀects of
a cholesterol-removing reagent and a cholesterol synthesis
inhibitor on viral infectivity have demonstrated the require-
ment of membrane rafts in ﬁlovirus entry [12, 15]. The entry
process of pseudotypes and virus-like particles bearing gly-
coproteins of Zaire Ebola virus and Lake Victoria Marburg
virus appears to occur through multiple pathways includ-
ing dynamin-dependent (clathrin-dependent and caveola-
dependent endocytosis) and dynamin-independent path-
ways such as macropinocytosis that is enhanced by Axl, a
plasma membrane-associated Tyro3/Axl/Mer (TAM) family
member, although Axl is not a receptor for ﬁloviruses [14].
Ebola fusion peptide, a hydrophobic helical domain that
belongs to the GP2 membrane fusion protein of Ebola virus,
is sensitive to interaction with membrane rafts, suggesting
the involvement of membrane rafts in the fusion process of
Ebola virus during entry into cells [13].
Flaviviruses enter cells through receptor-mediated endo-
cytosis and are delivered into acidic endosomes, leading to
release of viral genomic RNA into the cytoplasm by uncoat-
ing of the virion. Severe disease caused by WNV infection
is manifested as neurological symptoms such as meningitis,
encephalitis, and poliomyelitis. A nonpathogenic laboratory
strain of WNV (Sarafend strain) binds to αVβ3 integrin as a
viral receptor and enters cells through a clathrin-dependent
endocytic pathway and activation of focal adhesion kinase
(FAK) [56, 57]. However, NY385-99 strain of WNV utilizes a
raft-mediated endocytic pathway that is not associated with
αVβ3 integrin and FAK activation [16]. Use of membrane
rafts in the entry process depends on the virus strain.
DEN, an important arthropod-borne human pathogen,
is clinically manifested from a simple self-limited febrile ill-
ness known as dengue fever to a hemorrhagic fever and po-
tentially fatal hemorrhagic shock syndrome. Reported can-
didates of the DEN receptor for the entry process include
dendritic cell-speciﬁc ICAM 3-grabbing nonintegrin (DC-
SIGN)[58],heparansulfate[59],heatshockproteins(HSPs)
[18],andneolactotetraosylceramide[60].HSP90andHSP70
are part of a receptor complex of DEN and are associated
with membrane rafts essential for virus entry into neurob-
lastoma cells and human monocytes/macrophages [18, 19].
DC-SIGN is present in membrane rafts [61], and neo-
lactotetraosylceramide is a sphingolipid within membrane
rafts. One of risk factors of hemorrhagic fever and fatal
hemorrhagic shock syndrome after secondary infection with
as e r o t y p ed i ﬀerent from the primary infection is probably
antibody-dependent enhancement (ADE), which can be ex-
plained by the hypothesis that preexisting nonneutralizing
antibodies will generate immune complexes with a new sero-
type secondary-infecting DEN, leading to enhancement of
the capacity to infect macrophages and other FcΥ receptor-
(FcΥ-) bearing cells. The ADE of DEN-4 infection in the
human myelomonocyte cell line U937 has been suggested
to require membrane rafts [20] .T h ee n t r yp r o c e s so fJ E V ,
the leading cause of acute encephalitis in South-East Asia,
also requires membrane rafts in neural stem/progenitor cells
[19, 21], possibly via the putative receptor HSP70 [62]a n d
heparin sulfate [63] like DEN. The phosphatidylinositol-3
kinase (PI3K)/Akt pathway is activated through membrane
raftsasasignalplatformduringearlyJEVinfection,resulting
in increased production of the infectious progeny viruses
[21].
HCV is a major cause of chronic liver disease, including
chronic hepatitis, hepatic steatosis, cirrhosis, and hepatocel-
lular carcinoma. A cholesterol-removing reagent has an inhi-
bitory eﬀect on HCV entry through the virus receptor CD81
within membrane rafts [22]. Sphingomyelin hydrolysis
shows a strong inhibitory eﬀect on HCV entry, because cera-
mide enrichment of the plasma membrane leads to a dec-
reased level of CD81 at the cell surface membrane by enhan-
cement of CD81 internalization [23]. Thus, the entry process
of HCV through CD81 is partially dependent on some major
raft components, such as cholesterol and sphingomyelin, at
the cell surface membrane.
EBV is a human herpesvirus causing infectious mononu-
cleosisandisassociatedwithavarietyofhumanlymphocytic
and epithelial neoplasms, including Burkitt’s lymphoma and
nasopharyngeal carcinoma. EBV can recognize human com-
plement receptor type 2 (CR2), also known as CD21, on the
cellsurfacemembraneof Blymphocytes [24,64].Complexes
of CD21 with CD19 and palmitoylated CD81 are present in
membrane rafts. CD19/CD21/CD81 complexes in part sta-
bilize B-cell antigen receptor (BCR) within membrane rafts,
thus leading to enhancement of BCR-mediated signaling
[25].
HSV, belonging to the family of alphaherpesvirus, is a
pathogen causing mucosal lesions of the mouth and genital
organs in humans. HSV binds to and enters host cells
through complicated processes involving the essential viral
glycoproteins B (gB), gD, gH, and gL and multiple cellular
molecules including the tumor necrosis factor receptor
(TNFR) family [65], nectin-1 or nectin-2 (two members of
the immunoglobulin superfamily) [66], paired immunoglo-
bulin-like type 2 receptor (PILR) [67], and a particular type
of modiﬁed HSPGs [68, 69]. The association of TNFR with
membrane rafts is essential for tumor necrosis factor alpha-
(TNFα-) mediated nuclear factor-kappaB (NF-κB) activa-
tion [70]. Similarly, the association of HSPG with membrane
rafts is correlated with protein kinase C alpha (PKCα)a c t i -
vation [71]. Nectin-1 binding to gD of HSV-1 is not asso-
ciated with membrane rafts either before or during HSV-1
infection in severalcelllines. In the absenceofαVβ3-integrin,
HSV-1utilizesraft-independentanddynamin2-independent
pathways to reach the intracellular neutral pH compartment,
where the viral envelope fuses with the plasma membrane
[27]. The gB, but not gC, gD, or gH, of HSV-1 is associated
with membrane rafts aftervirus attachment and during virus
entry. Moreover, a cholesterol-removing reagent results in
inhibition of HSV-1 and pseudorabies virus entry [26, 28].
These ﬁndings indicate that gB may interact with a cellular
moleculewithinmembraneraftsthatmayserveasaplatform
for HSV-1 entry and cell signaling. Also, αVβ3-integrin ex-
pressiononnectin-1-positivecellsallowsHSV-1toentercellsBiochemistry Research International 5
througharaft-dependentanddynamin2-dependentpathway
and reach the intracellular acidic compartment, where the
viral envelope fuses with the plasma membrane. The path-
way dictated by αVβ3-integrin utilizes membrane rafts, the
platforms for a number of Toll-like receptors, suggesting that
αVβ3-integrin functions as a sentinel of innate immunity
[27].
HHV-6, a betaherpesvirus related to human herpesvirus
7a n dh u m a nc y t o m e g a l o v i r u s ,i sah u m a np a t h o g e no fe m -
erging clinical signiﬁcance. Human CD46, a cellular receptor
for HHV-6, is not associated with membrane rafts in unin-
fected cells. However, after virus attachment, CD46 is local-
ized to membrane rafts. When membrane rafts are disrupted
by a cholesterol-removing reagent or rescued by addition of
exogenous cholesterol, the entry process of HHV-6 is inhi-
bited or partially recovered, respectively. Membrane rafts
appear to play an important role in the HHV-6 entry process
as an entry site on the host cell surface [29].
HHV-8, the most recently identiﬁed member of human
gammaherpesviruses, is consistently identiﬁed in all forms
of Kaposi’s sarcoma, primary eﬀusion lymphoma, and mul-
ticentric Castleman’s disease. Reduced HHV-8 infection and
decreased cellular signals associated with the virus infection
by raft disruption suggest that membrane rafts in microvas-
cular dermal endothelial cells are required for HHV-8 infec-
tion and gene expression, due to their potential roles in the
modulation of HHV-8-induced PI3K, RhoA-GTPase, and
Diaphanous-2 (a RhoA-GTPase-activated adaptor molecule
involved in microtubule activation) signal molecules, which
play roles in virus entry processes after receptor binding
[30]. Although activation of these signals involved in actin
dynamics plays an important role in the entry process and
endosomal sorting of HHV-8, the virus enters cells mainly
through a clathrin-dependent pathway, but not a raft-depen-
dent pathway, in endothelial cells [31].
Inﬂuenza viruses, highly transmittable pathogens of sev-
ere acute respiratory symptoms in various animals including
humans, avians, and swines, enter host cells through mul-
tiple pathways including clathrin-independent endocytosis,
caveola-independent endocytosis, and macropinocytosis de-
pending on the cell type [33, 35–37] after binding of a
viral envelope glycoprotein, hemagglutinin (HA), to glyco-
conjugates containing sialic acid on the cell surface [72,
73]. The viruses carried to late endosomes acquire fusion
activity of HA given by its low-pH-dependent conformation
change, leading to membrane fusion between the virus and
endosomes. The viral ribonucleoprotein (RNP) complexes
including the viral RNA genome are then released to the
cytoplasm of host cells by proton inﬂux of viral ion channel
M2 protein that requires binding with cholesterol [32, 74].
HA concentration to membrane rafts provides a suﬃcient
amount of HA for the progeny virus envelope so that it can
express eﬃcient fusion activity for cellular membranes [34].
Inﬂuenza virus and capsid-like core particles of hepatitis B
virus(Hepadnaviridae)canalsointernalizethroughclathrin-
dependent endocytosis alone without the use of membrane
rafts [75].
Vaccinia virus had been established as a vaccine that era-
dicated smallpox disease. Immediately after virus infection,
the viral envelope proteins A14, A17L, and D8L, but not
H3L,arepresentinmembraneraftsonthecellsurface.Initial
attachment of the virus to viral receptor glycosaminoglycans
is not required for such membrane raft formation. On the
other hand, cholesterol-containing membrane raft forma-
tion with these viral envelope proteins is observed when vac-
cinia virus penetrates into a wide variety of mammalian cells
from diﬀerent hosts [38].
HIV-1,apathogencausinglong-termandchronicdisease
thatgraduallyprogressestoacquiredimmunodeﬁciencysyn-
drome, binds to viral receptor CD4 on the cell surface by the
viral envelope glycoprotein gp120. Conformational change
ofgp120 afterreceptorbinding leadsto interactionwithviral
coreceptors, chemokine receptor CXCR4 or CCR5, and a
subsequent conformational change of the viral envelope gly-
coprotein gp41 that confers membrane fusion activity [76–
78]. Approximately 11–18% of CCR5 in human adenocarci-
noma cells, 90–95% of CD4 in H9 leukemic T cells, and 50–
66%ofCD4inperipheralbloodmononuclearcells(PBMCs)
are detected in membrane rafts [79, 80], whereas CXCR4 is
almost entirely absent in membrane rafts of human embry-
onic kidney 293T cells, H9 leukemic T cells and PBMCs
[39, 80]. However, recent research indicates that the viral
clustering of coreceptor CXCR4 in membrane rafts on 293T
cells (not human glioma NP2 and human rhabdosarcoma
TE671), rather than that of the viral receptor CD4, is the
key step for the entry process of HIV-1 [44]. Interactions
between CD4 and CCR5, which occur outside membrane
rafts, have been postulated to inﬂuence susceptibility to the
entry process of CCR5-tropic HIV [81]. A recent study has
demonstratedthatCD4andCCR5inmacrophagesareparti-
tionedtomembraneraftsandhassuggestedthatmacrophage
membrane cholesterol is required for the entry process of
HIV, implicating involvement of membrane rafts [43]. Addi-
tionally, glycosphingolipids abundantly present in mem-
brane rafts of host cells, such as Gb3Cer, GM3 gaglioside,
and galactosylceramide, have been shown to be involved in
theinteractionwithviralglycoproteinsandinthevirusentry
process [45, 82–85]. The presence of Gb3Cer within mem-
brane rafts in glomerular cells, but not tubular cells, may
play a role in HIV nephropathy through binding of gp120
[86]. However, HIV-1 entry into primary human brain
microvascular endothelial cells appears to be a raft-indepen-
dent mechanism associated with proteoglycans such as cell-
associated heparin sulfate and chondroitin sulfate [87].
HTLV-1, an oncogenic pathogen causing human adult T
cell leukemia, enters host cells through glucose transporter 1
(GLUT-1) [88] that is targeted to membrane rafts for glucose
deprivation [89]. Inhibition of vial entry and syncytium
formationoftheinfectedcellsbyacholesterol-removingrea-
gent suggests the involvement of membrane rafts in the entry
a n df u s i o np r o c e s s e so fH T L V - 1[ 46, 47].
Alphaviruses such as Semliki Forest virus and Sindbis
virus, arthropod-borne pathogens of infectious arthritis and
rashes being the most commonly observed, require cho-
lesterol for the virus entry process and especially for the
membrane fusion process between the virus and the endo-
some triggered by low pH of acidic endosomes [48, 49,
52]. Direct binding of E1 fusion protein of Semliki Forest6 Biochemistry Research International
virus to cholesterol promotes viral fusion and infection in
a cholesterol-dependent manner, unlike ﬂaviviruses such as
DEN and yellow fever virus, which show no signiﬁcant
binding of viral fusion proteins to cholesterol [90]. However,
alphavirusesmaynotrequiremembraneraftsforcholesterol-
dependent promotion of fusion with target membrane [51].
Similarly, the entry process of lymphocytic choriomeningitis
virus(LCMV;Arenaviridae)isalsoknowntoberaftindepen-
dent but to require membrane cholesterol [4]. Cholesterol
dependence may not necessarily be linked to the function of
membrane rafts for the virus entry process.
4. Entry of Nonenveloped Viruses
Entry processes of nonenveloped viruses associated with
membrane rafts have been investigated for species C human
adenovirus (HAdV; Adenoviridae)[ 91, 92], Coxsackie virus
A9, B3, and B4 (Picornaviridae)[ 93–96], echovirus types
1a n d1 1( Picornaviridae)[ 97–102], enterovirus (Picornavi-
ridae)[ 98], Rhinovirus (Picornaviridae)[ 103], BK virus (Pa-
povaviridae)[ 104–106], bovine papillomavirus (Papovaviri-
dae)[ 107], human papillomavirus (HPV; Papovaviridae)
[108–116], JC virus (Papovaviridae)[ 117], simian virus 40
(SV40; Papovaviridae)[ 118–126], bluetongue virus (Reoviri-
dae)[ 127], and Rotavirus (Reoviridae)[ 128–130].
HAdV, a common pathogen of acute respiratory disease
and epidemic keratoconjunctivitis, is frequently used as viral
vectors for gene therapy, most of which are serotype 5 that
generally utilize a clathrin-dependent endocytic pathway.
Initial interaction of HAdV with the cellular coxsackievirus
and adenovirus receptor (CAR) and heparin sulfate glycos-
aminoglycans [131] is followed by interaction of the RGD
motif of the virus with αVβ3, αVβ5, αMβ2,a n dα5β1 inte-
grins, resulting in clathrin-dependent entry of HAdV into
hematopoietic cells. In contrast, mature B-cell plasmocytes
and Chinese hamster ovary (CHO) cells, which are CAR-ne-
gative cell lines, are permissive to HAdV2, HAdV4, and
HAdV5, probably through a clathrin-independent and cave-
ola/raft-dependent endocytic pathway [91, 92].
Coxsackievirus A9 infection is one of the most frequent
causes of aseptic meningitis and causes various symptoms
such as ﬂaccid paralysis, respiratory disease, and chronic
myocarditis. This virus utilizes αVβ3 i n t e g r i na sav i r a lr e -
ceptor, glucose-regulated protein 78 (GRP78) as a viral core-
ceptor, and accessory molecule major histocompatibility
complex class I (MHC-I) for the entry process. Receptor
molecules αVβ3 i n t e g r i na n dG R P 7 8a sw e l la sM H C - I
are concentrated as a virus entry site in membrane rafts fol-
lowing virus infection. The relationship between activation
of Raf/mitogen-activated protein kinase (MAPK) within
rafts during infection and virus entry is unclear [93, 94].
Coxsackievirus B4 is a human pathogen causing insulin-de-
pendent diabetes mellitus, also known as type I diabetes, by
progressive destruction of pancreatic β cells. Attachment of
this virus to viral receptor molecules, CAR and CD55, seems
to induce the recruitment of these molecules into membrane
rafts. Internalization of Coxsackievirus B4 rapidly to the
Golgi apparatus is independent of clathrin and appears to
be dependent on membrane rafts. However, it has been
suggested that CAR can also follow the clathrin-mediated
pathway [95] .C o x s a c k i e v i r u sB 3i sah u m a np a t h o g e nc a u s -
ing febrile illness, meningitis, and myocarditis. Coxsackie-
virus B3 Nancy strain cannot bind to the glycosylphospha-
tidylinositol-(GPI-) anchored complement regulatory pro-
tein decay-accelerating factor (DAF), but RD strain, a DAF-
binding derivative of Nancy strain, can. Coxsackievirus B3
RD strain possessing the ability of DAF binding enters polar-
ized human intestinal Coca-2 cells through a caveola-depen-
dent but dynamin-independent pathway that requires DAF-
mediated tyrosine kinase signals, whereas entry of this strain
into nonpolarized HeLa CCL-2 cells requires dynamin and
membrane rafts with CAR but not clathrin or caveolin,
indicating that the entry pathway of this virus is dependent
on cell type such as polarized and nonpolarized cell lines and
that the requirement of membrane rafts diﬀers signiﬁcantly
from that of caveolin for virus entry. Coxsackievirus B3
Nancy strain possessing no ability of DAF binding utilizes an
entry mechanism similar to that of the RD strain in HeLa
CCL2 cells, suggesting no inﬂuence of DAF binding on virus
entry into HeLa CCL2 cells [96].
Echovirus type 1 and a number of enteroviruses includ-
ing echovirus type 11 cause nerve paralysis, cerebral menin-
gitis, respiratory symptoms, and anathema. These viruses
utilize α2β1 integrin and DAF on the cell surface as the
respective receptors, which induce caveola-dependent and
membrane raft-dependent endocytosis [97–101]. However,
a recent study has suggested that binding of clustered α2β1
integrin with echovirus type 1 initiates a unique entry path-
way that is p21-activated kinase 1 (Pak1), GTP-binding pro-
tein Rac1, PI3K, phospholipase C (PLC) and actin-depen-
dent but clathirin and caveolaindependent and that can sort
c a r g ot oc a v e o s o m e s[ 102].
Rhinoviruses, general pathogens of cold and acute respi-
ratory symptoms, colocalize with ceramide-enriched mem-
brane platforms during infection. Rhinoviruses induce mi-
crotubule- and microﬁlament-mediated translocation of
acid sphingomyelinase from an intracellular compartment
onto the extracellular leaﬂet of the cell membrane. The enzy-
matic activity of acid sphingomyelinase hydrolyzes sphin-
gomyelin to ceramide in the cell membrane, ﬁnally leading
to the formation of large ceramide-enriched membrane plat-
forms. Genetic and pharmacological prevention of acid sph-
ingomyelinase has shown the involvement of ceramide-en-
riched membrane platforms in Rhinovirus entry [103].
Although previous studies have shown the existence of many
receptors for Rhinovirus entry, ninety percent of human
Rhinovirus immunogenic variants use intercellular adhesion
molecule-1 (ICAM-1) as a receptor [132–134], which is
known to be a component of ganglioside GM1-containing
membrane rafts [135].
HPVs are well-established pathogens causing cervical
cancer and have also been implicated as pathogens in other
epithelialcancers,includingheadandneckcancers.Over100
diﬀerent types of HPV, including types 16, 18, 31, 33, 35, 39,
45, 51, 52, 56, 58, 59, 66, and 68 as high-risk carcinogenic
HPVs and types 6, 11, 32, 34, 40, 42, 43, 44, 53, 54, 55, 61,
70, 72, 73, 81, 83, 84, 89, and Pap155 as low-risk HPVs,
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etiologic agent for anogenital malignancies, particularly cer-
vical cancer [136]. Increased expression of HPV type 18 by
addition of cholesterol suggests involvement of the HPV
infection cycle in membrane rafts [109] .Th ee n tryp r oc e s so f
HPV begins with viral binding to speciﬁcally modiﬁed hep-
aran sulfate proteoglycans (HPSGs), most likely syndecans.
In addition, α6 integrin and laminin 5 have been suggested
to be transient receptors for HPV. Although association of
HSPGs with membrane rafts has been shown [71], binding
of HPV type 33 pseudovirus to HSPGs is followed by delayed
caveola-independent endocytosis [110]. Interestingly, the
entry process of HPV types 16 and 58 involves clathrin-de-
pendent endocytosis, whereas that of HPV type 31 involves
caveola-dependent endocytosis, indicating that HPVs use
distinct routes for entry into COS-7 cells (a monkey kidney
cell line) [111]. In human keratinocytes (a natural host
cell type of HPVs), remarkably slow entry and initiation of
HPV type 31 early infection require both caveolin-1 and
dynamin-2 (entry half-time of approximately 14h), diﬀerent
from fast clathrin-dependent endocytosis of HPV type 16
(entry half-time of 4h) [114]. Both HPV types 16 and 31
require the acidic compartment of the endosomal pathway,
where low pH induces a conformational change in the HPV
capsid to promote viral genome uncoating. Binding of and
infection with HPV type 16, but not HPV type 31, require
HPSGs in human keratinocytes. The diﬀerent mechanisms
of these two HPV types may reﬂect the distinct binding
requirement [115]. However, in COS-7 cells, and 293TT
cells (a simian virus 40 large T antigen-transformed human
kidney cell line), HPV type 31, like HPV type 16, enters the
cells through a clathrin-dependent pathway rather than a
caveola-dependent pathway as described above [113]. HPV
type 16 also uses a novel endocytic pathway associated with
tetraspanins CD63 and CD151 in HeLa cells, independently
of clathrin and caveolin [116]. Complexes of tetraspanins
CD63 and CD151 with α6 integrin and laminin through
β4 palmitoylation of these tetraspanins induce assembly of
cholesterol-associated microdomains that are distinct from
membrane rafts [137, 138]. These tetraspanin-enriched mi-
crodomains may serve as an entry platform of HPV type
16. The diﬀerent entry routes for HPV types 16 and 31
might result from diﬀerent host cell types, such as human
keratinocytes, COS-7 cells and 293TT cells, and from depen-
dency of HPV lifecycles on cell diﬀerentiation. Although the
involvement of distinct endocytic pathways in HPV type-
dependent pathogenicity remains unclear, results obtained
from human keratinocytes, a natural host cell line of
HPVs, may be close to the truth of the entry process.
BK virus, a pathogen of an infectious complication termed
polyomavirus-associated nephropathy in renal transplant
recipients, enters Vero cells and human renal proximal tubu-
lar epithelial cells by a slow caveola-dependent and clathrin-
independent pathway in a pH-dependent manner [104–
106]. JC virus and bovine papillomavirus enter cells through
clathrin-dependent endocytosis and are subsequently trans-
ported from early endosomes to caveolar vesicles and then
carried by a slow caveola-dependent pathway [107, 117].
Caveola-dependent endocytosis has been studied mostly
by analysis of cell entry of polyomaviruses represented by of
SV40, which causes cancer in some animals through repres-
sion of tumor suppressor p53 [139]. After SV40 attaches to
MHC-I on the cell surface, caveola and caveolin-1 are rec-
ruited to the association site of SV40 [140, 141]. Then virus-
incorporated caveola undergoes budding from the cellular
membrane after activation of tyrosine kinases, actin skeleton
depolymerization, actin tail formation, and dynamin accu-
mulation around the association site [121, 123]. Finaly, cave-
olacarriesthevirustotheendoplasmic reticulum(ER)along
cellular microtubules. SV40 receptor MHC-I is not localized
in membrane rafts, but attachment induces association of
the virus with caveola [118–122] or ganglioside GM1 that is
enriched in membrane rafts as a viral receptor [124, 125].
As for other polyomaviruses, BK virus and JC virus, but
not mouse polyomavirus, have been reported to use caveola-
dependent endocytosis for the entry process [104–106, 117,
142]. Bluetongue virus-1 can infect baby hamster kidney
(BHK) cells through an entry process that is clathrin depen-
dent and cholesterol dependent but requires dynamin [127].
Rotaviruses, pathogens of severe diarrhea in infants and
young children, recognize several molecules on the epithelial
cell surface, including glycolipids, N-glycoproteins, HSC70
protein, and αVβ3 integrin localized in membrane rafts [128,
129].
5. Role of Membrane Rafts in Virus Genome
Replication, Assembly, and Budding
Evaluation of the role of membrane rafts in viral assembly
and budding has been performed by examining the inhi-
bitory eﬀect of progeny virus formation and production
when membrane rafts are disrupted by a cholesterol-re-
moving reagent or a cholesterol synthesis inhibitor. In chole-
sterol-depleted infected cells, impaired virus formations and
productions are recovered by the addition of exogenous
cholesterol. General biochemical methods have also been
used to determine whether several viral structural proteins
during the process of virus formation and assembly are colo-
calized with the detergent-insoluble fraction or a represen-
tative raft-marker such as caveolin-1, ﬂotillin, or GM1. Raft-
dependent virus budding and replication have also been eva-
luated by examining the inhibitory eﬀect of caveola forma-
tion using an RNAi method and dominant-negative protein
expression for normal caveolin-1 knockdown. If the raft-
association sites have been identiﬁed in the viral structural
proteins, it is possible to generate mutated viral proteins
that do not associate with membrane rafts. Then evaluation
of virus assembly and budding in membrane rafts can also
be performed by measuring intracellular transport or incor-
porationrateofthesemutatedproteinsintovirusparticlesor
characterization of viruses possessing these mutated proteins
generated by established reverse genetics methods. When
virus budding of enveloped viruses occurs in membrane
rafts, colocalization of the budded virus and a raft marker
on the cell surface membrane can be observed by using an
electronic microscope.8 Biochemistry Research International
6. Genome Replication, Assembly, and
Budding of EnvelopedViruses
The role of membrane rafts in viral RNA synthesis of en-
veloped viruses has been investigated for hepatitis C virus
(HCV; Flaviviridae)[ 86, 143–147], DEN [148, 149], JEV
[148], and respiratory syncytial virus (RSV; Paramyxoviri-
dae)[ 150, 151].
Association of HCV nonstructural (NS) proteins with
cholesterol-enriched membrane rafts in the Golgi-derived
membrane results in the formation of the replication com-
plexes (distinct particle structures of about 0.7μmi ns i z e )
for HCV RNA synthesis [86, 143, 144]. A lipophilic long-
chainbasecompound,NA255,hasbeenidentiﬁedasasmall-
molecule HCV replication inhibitor from a secondary fungal
metabolite. NA255 disrupts the association of HCV NS pro-
teins with membrane rafts by prevention of the de novo syn-
thesis of sphingolipids, major membrane raft components
[145]. The sphingomyelin-binding domain of HCV RNA-
dependent RNA polymerase is the membrane raft localiza-
tiondomainofviralnonstructuralproteinNS5B[146].Since
cholesterol-depleted or sphingomyelin-hydrolyzed virus has
a defect in cellular internalization but not cell attachment,
incorporation of cholesterol and sphingolipid into HCV
particlesalsoplaysanimportantroleinvirusmaturationand
infectivity.Althoughnewlysynthesizedstructuralproteinsof
HCV localize into membrane rafts on the cellular membrane
of infected cells, it is unclear whether these membrane
rafts are derived from lipids on the viral particles or not.
Alternatively, membrane rafts may serve as a budding site of
HCV in the ER [147].
On the cell surface and in the viral RNA replication com-
plexes,membraneraftsareassociatedwiththeNS1ofallfour
DEN serotypes and JEV. Eﬃcient viral RNA replication of
ﬂaviviruses requires NS1, which can be found in the cell as
a monomer associated with cellular organelle membranes
and colocalized with the viral replication complex and as a
dimer in a membrane GPI-anchored form colocalized with
membrane rafts, and it is also secreted as a hexamer from
infected cells [148, 149].
Human RSV is a major pathogen of severe lower respi-
ratory tract disease in infants, children, immunosuppressed
individuals,andtheelderly.Theviralproteins,nucleoprotein
(N),phosphoprotein (P),large polymerase subunit (L), mat-
rix protein (M) and M2-1, are located in membrane rafts
in virus-infected cells. Viral RNP complexes are formed by
interactions of viral genomic RNA with N, P, L, and M2-
1 proteins. The association of viral RNP complexes with
membrane rafts leads to eﬃcient RNA polymerase activity
that may require interaction with cellular factor HSP70 (one
of the viral receptor candidates) in a raft-dependent and
ATP-dependent manner [150, 151].
The role of membrane rafts in the assembly and budding
of enveloped viruses has been investigated in Ebola virus
[12, 152], Marburg virus [12], WNV [153], murine cyto-
megalovirus (MCMV; Herpesviridae)[ 154], HSV [155, 156],
HHV-6 [157], inﬂuenza virus [34, 40, 158–171], measles
virus (Paramyxoviridae)[ 40, 172, 173], Newcastle disease
virus (NDV; Paramyxoviridae)[ 174, 175], RSV [150, 151,
176–179], Sendai virus (Paramyxoviridae)[ 180, 181], HIV-1
[40, 182–201], HTLV-1 [202], and vesicular stomatitis virus
(VSV; Rhabdoviridae)[ 203, 204].
Ebola virus and Marburg virus use membrane rafts bear-
ing viral glycoproteins as a platform for budding from host
cells, in addition to entry. Hence, released virus particles
incorporate the raft-associated molecule GM1 but not trans-
ferrin receptor, a protein absent from membrane rafts [12].
The matrix protein VP40 of Ebola virus, which plays an es-
sential role in virus assembly and budding, oligomerizes in
membrane rafts. The cellular TSG101 protein, a component
of the vacuolar protein sorting machinery, actively targets
along with VP40 to membrane rafts at the cell surface, by
binding of VP40 with a PTAP motif of TSG101. Thus, bud-
ding complexes containing VP40 and TSG101 accumulate in
membrane rafts to promote virus budding [152].
WNV spreads from the blood stream to the central ner-
vous system and peripheral tissues across endothelial cells.
Virus-likeparticlesofhighlyvirulentWNVNY996-LPstrain
are transported from the apical side to basolateral side of
endothelial cells as the virus budding site in a raft-dependent
manner, whereas those of low-virulent WNV Eg101 strain
are hardly transported. Membrane rafts may be involved in
a transport pathway for basolateral destinations of WNV
within endothelial cells [153].
MCMV (belonging to the betaherpesvirus UL78 fam-
ily) M78 protein, a 7-transmembrane receptor homologue,
traﬃcs to the surface membrane of infected cells, but is
rapidly and constitutively internalized through both clath-
rin-dependent and caveola/raft-dependent pathways. Such
an M78 subcellular localization may contribute to the incor-
poration of M78 into the viral envelope during virus matu-
ration [154].
Six envelope glycoproteins, gH, gL, gQ1, gQ2, g, and gB,
of HHV-6 are present in membrane rafts during the course
of virus maturation. GM1, a representative raft marker, is in-
corporated into mature virus particles along with these viral
envelopeglycoproteins,indicatingthatHHV-6mayassemble
through membrane rafts [157].
The HSV tegument contains the less-abundant virus
particle host shutoﬀ (vhs) protein encoded by the HSV late
gene UL41, which enhances the turnover of all kinetics of
viral mRNA and is likely to be important in the increased
removal of immediate-early and early viral transcripts to
facilitate the switch to late gene expression. Only a small pro-
portion of total cellular vhs proteins are associated with
membrane rafts. Nevertheless, a large proportion of the vhs
proteins exist in HSV-containing cytoplasmic organelles, in-
dicating that membrane rafts may correlate with assembly of
vhs protein into the tegument [155]. The UL11 and UL51
gene products of HSV are membrane-associated tegument
proteins that are incorporated into the HSV envelope during
virus maturation. HSV UL11 is associated with cholesterol-
and glycosphingolipid-enriched membrane rafts through its
posttranslational myristoylation and palmitoylation into the
Golgi apparatus, but UL51, which is only palmitoylated,
has no association with the membrane rafts. UL11 and
UL51 appear to function at diﬀerent steps in progeny virusBiochemistry Research International 9
maturation [156]. Involvement of membrane rafts in HSV
assembly and budding remains to be clariﬁed.
Inﬂuenza virus particles consist of vial RNP with two
spike envelope glycoproteins, HA and neuraminidase (NA),
andionchannelM2proteinontheoutersurfaceandinternal
M1 protein and nonstructural NS2 protein on the inner sur-
face. Membrane rafts are associated with the transmembrane
domains and cytoplasmic tails of HA [162]a n dN A[ 162,
163] and with the short transmembrane domains of M2
[74, 169, 205]a n dN P[ 164], but not M1. These domains
of HA and M2 contain palmitoylated cysteine residues that
are required for hydrophobic interactions with lipids and
cholesterol of membrane rafts. M2 also possesses a puta-
tive cholesterol recognition/interaction amino acid consen-
sus(CRAC)motifinadditiontopalmitoylationofitsamphi-
philic helix. The targeting to membrane rafts of M2 requires
the palmitoylation but not the CRAC motif [171]. Although
the transmembrane domains and the cytoplasmic tails of
NA are essential for the association with rafts, there is no
evidence that NA contains palmitoylated cysteine residues.
The mechanism by which NP associates with rafts remains
unknown. HA, NA, NP, and M2 independently use mem-
brane rafts together with each apical targeting signal se-
quence for the apical sorting process, leading to eﬃcient pre-
ferential budding and release of progeny viruses from the
apical surface membrane. However, membrane rafts are not
necessarily required for apical sorting of these viral proteins,
indicating that apical sorting machineries of these viral pro-
teins also exist outside their membrane rafts [158, 160–
162, 164]. For example, cellular protein VIP17/MAL, a raft-
associated protein, is involved in apical transport of HA in
dog kidney MDCK cells [206]. M1, a non-raft protein, is
incorporated into membrane rafts through its interactions
with cytoplasmic tails of both HA and M2, which facilitate
the recruitment of internal viral proteins and viral RNP to
the cell surface membrane for eﬃcient virus assembly and
budding [162, 207]. Although M1 has been believed to play a
critical role in viral assembly and budding [208, 209], recent
studies have indicated that HA, NA, and M2, but not M1, are
required for assembly and budding of inﬂuenza virus par-
ticles [167, 169].
GM-95 cells are mutant cells of mouse B16 melanoma
that cannot synthesize major glycosphingolipids including
gangliosidesduetolackofceramideglycosyltransferasegene,
the ﬁrst enzyme of glucosylceramide series synthesis. GM-
95 cells can be infected by inﬂuenza A viruses and produce
infectious progenyviruses,regardlessof theabsenceofmajor
glycosphingolipids [73]. Since gangliosides are major com-
ponents of rafts and viral receptors, it has been suggested
that they are not absolutely necessary for the inﬂuenza virus
lifecycle. This suggestion for virus assembly and budding is
supported by evidence that infectious progeny viruses can be
produced from cells infected with mutant viruses possessing
HA and NA that lack the ability to interact with membrane
rafts by mutations of their raft-binding domains [34, 163]
and that membrane raft disruption enhances virus budding
from MDCK cells [168]. How membrane rafts help the in-
ﬂuenza virus lifecycle needs to be addressed in future studies.
The concentration and clustering of HA and NA in the same
membrane rafts facilitate eﬃcient incorporation of these
raft-associated viral proteins into the progeny viral mem-
braneduringthebuddingprocess[34,163],becauseprogeny
virus particles are selectively budded together with mem-
brane rafts from the cell surface [159]. At that time, M2
is distributed in a diﬀerent type of membrane rafts from
those associated with HA and NA or is located in non-raft
compartments on the cell surface, resulting in poor incor-
poration into the progeny viral membrane [165]. On the
other hand, a study has shown that M2 interacts with mem-
brane rafts associated with HA dependent on an intact actin
cytoskeletonandtherebyM2targetstotheraftlipid-enriched
zone, the viral budding site on the cell surface membrane,
organizedbyHA[170].Disruptionofmembraneraftsresults
in decreased infectious progeny virus production concomi-
tantly with enhancement of the release total infectious and
noninfectious virus particles from infected cells [168]. Taken
together, the results of studies indicate that the role of mem-
brane rafts in the inﬂuenza virus lifecycle is contribution
to an eﬃcient incorporation of raft-associated viral proteins
into the progeny viral membrane and pinchingoﬀ of virus
particles from the plasma membrane.
In infected cells, the tight association of newly synthe-
sized HA transferred to the cell surface with membrane rafts
stimulates cellular Raf/MEK/ERK signaling of the MAPK
pathway through PKCα activation. MPAK activation induces
nuclear export of viral RNP compexes from the nucleus to
the cytoplasm, leading to enhanced production of infectious
progeny viruses [166]. Our recent study has shown that
sulfatide, 3-O-sulfated galactosylceramide, is required for ef-
ﬁcient virus replication and that association of newly synthe-
sizedHAtransferredtotheinfectedcellsurfacewithsulfatide
inducesnuclearexportofviralRNPcomplexesfromthenuc-
leus to the cytoplasm, leading to enhanced production of
i n f e c t i o u sp r o g e n yv i r u s e s[ 210]. Thus, association of HA
with sulfatide may trigger MAPK activation that enhances
nuclear export of viral RNP complexes. Some studies have
shown that existence of sulfatide associated with membrane
rafts [211, 212], but lipid composition in the puriﬁed in-
ﬂuenza virus envelope propagated in embryonated eggs does
not contain any acidic glycosphingolipids including sulfatide
[162]. Further investigation is needed to determine whether
enhanced nuclear export of viral RNP is triggered by raft-as-
sociated or non-raft sulfatide.
Measlesvirusisapathogenofanacuterespiratorydisease
and causes the death of over one million children each year,
principally because of virus-induced immunosuppression of
lymphocyte function. Membrane rafts act as a platform of
the virus assembly process but not the budding process. The
transmembrane domain of the viral surface fusion (F) pro-
tein has two palmitoylated cysteines, which probably interact
with membrane rafts [213]. The F protein is synthesized
as an inactive precursor (F0) that is proteolytically cleaved
in the trans-Golgi network and thereby converted to the
biologically active form, disulﬁde-linked subunits F1 and F2.
After transport of two mature viral envelope glycoproteins,
hemagglutinin (H) and F proteins, to the trans-Golgi net-
work, they are preferentially incorporated into membrane
rafts, but the F0 precursor is not. Internal structural proteins,10 Biochemistry Research International
M and N, interact with membrane rafts possibly through
acylation of saturated chains, regardless of the presence of
the two viral envelope glycoproteins. The nonstructural V
protein remains excluded from rafts during the course of
virus infection. Although the M protein can interact with the
cytoplasmictailoftheFproteininH-Fcomplexes,itcanalso
bind to plasma membranes and the N protein, thereafter in
turn binding to the viral internal structural proteins, P and
L. Eventually, M-RNP complexes (composed of viral internal
proteins N, P, and L with viral RNA) interact with the surface
membranethroughtheMproteinassociatedwithmembrane
rafts and with H-F complexes associated with membrane
rafts through the F protein, resulting in eﬃcient assembly of
measles virus prior to the budding process [172, 173].
NDV is a highly contagious pathogen of zoonotic bird
disease aﬀecting many domestic and wild avian species. The
assembly and budding of infectious progeny viruses prefer-
entially occur in membrane rafts that interact with the cor-
tical cytoskeleton [174]. Furthermore, intact membrane raft
domains in the infected cells, but not in the virus envelopes,
facilitate the proper formation or maintenance of the viral
surfacehemagglutinin-neuraminidase (HN) and F glycopro-
tein complexes (required for virus-cell membrane fusion)
and the incorporation of the HN-F complexes into the viral
surface, leading to the initiation of membrane fusion bet-
ween the virus and cell [175].
Human RSV is a major cause of severe lower respira-
tory tract disease in young children, the elderly, and immu-
nosuppressed adults. The viral envelope attachment G pro-
tein and the internal M and N proteins of RSV are present
in membrane rafts. Caveolin, a raft marker, is present in the
RSV envelope. RSV infection induces cellular distribution
of phosphocaveolin-1 that is enriched at sites of attachment
of the actin cytoskeleton. Therefore, RSV assembly at the
plasma membrane is shown to occur in specialized mem-
brane rafts that contain a high content of caveolin [176,
177]. The cytoplasmic tail of F protein plays an essential
role in its cellular localization and production of infectious
progenyviruses,dependentlyoninteractionofFproteinwith
membrane rafts [178]. Moreover, like the function of HIV-
1N e f[ 192], RSV infection facilitates production of phos-
phatidylinositol 4,5-bisphosphate (PIP2) and phosphatidyli-
nositol 3,4,5-triphosphate (PIP3) in the lipid composition of
membrane rafts within virus inclusion bodies through lipid
kinases containing PI3K. This change plays an important
role in the assembly and budding processes of progeny virus
[179].
Sendai virus, also known as murine parainﬂuenza virus
type 1, is a highly transmissible pathogen of respiratory tract
infection in mice, hamsters, guinea pigs, rats, and occasio-
nally pigs. The two viral envelope proteins, HN protein and
F protein, interactwith membrane rafts.The viralinternal M
proteinappearstohavenodirectassociationwithmembrane
rafts. When mature HN-F complexes speciﬁcally interact
with M proteins through both the cytoplasmic tail and the
transmembrane domain of F protein, the HN-F-M com-
plexes are localized in membrane rafts, where the viral pro-
teins have been suggested to be assembled [180]. However,
further study led to the conclusion that the virus assembly
complexes found in membrane rafts did not constitute a
directprecursorofvirusparticlebudding[181].Twopossible
routes, raft dependent and raft independent, seem to be in-
volved in Sendai virus assembly.
HIV-1usesmembraneraftsasaplatformforviralassem-
bly and budding [182, 188]. Modiﬁcation of the N-terminus
of HIV-1 Gag protein with myristic acid is required for HIV-
1assemblyandbudding[214].Gagproteininteractswiththe
plasma membrane through associations between its myristic
acids and membrane rafts, leading to its incorporation into
HIV-1 particles as an internal structural protein [188]. Dur-
ing the budding process, Gag-Gag interactions (Gag multi-
merization)occurthroughtheN-terminusoftheviralnucle-
ocapsid (NC domain). Lower-ordered Gag multimerization,
but not higher-order Gag multimerization, may enhance or
stabilize Gag-membrane and Gag-raft interactions. Whether
membrane rafts are responsible for increasing Gag-Gag in-
teraction is unclear [186]. The viral envelope glycoprotein
complexes (composed of gp120 and gp41) are incorporated
into the HIV-1 envelope together with membrane rafts by
interactions of Gag with the cytoplasmic tail of gp41, which
stabilizethegp120-gp41interactions.Palmitoylationincyto-
plasmictailsofgp41isrequiredforinteractionswithraftsbut
not for interactions between gp41 and Gag protein. More-
over, although associations of rafts with both gp41 and Gag
protein are not essential for HIV-1 assembly, infectious pro-
geny virus production, and surface traﬃcking of the viral
proteins [185, 189, 190], the quantal interaction of Gag with
cholesterol-enriched rafts facilitates HIV-1 particle produc-
tion by enhancement of both Gag-membrane interaction
and Gag multimerization [193, 194]. Interactions of Gag
proteinwithAnnexin2atthePIP2-enrichedmembranerafts
also increase virus production [196].
The Nef protein encoded by primate lentiviruses facil-
itates virus replication and thus increases the pathogenic
potential of HIV. The myristoylated N-terminus and its
neighboringbasicarginineandlysineresiduesofNefincrease
viral transcription and HIV-1 infectivity through interac-
tions with GM1- and cholesterol-enriched membrane rafts,
where Nef binds to both the plasma membrane and the viral
structural proteins and participates directly in formation of
thebuddingscaﬀold,leadingtoincorporationofNefintothe
virus particles, concomitantly with viral structural proteins
[183, 184, 187]. The N-terminus of Nef determines its diﬀer-
ential membrane avidity and its preferential incorporation
into a speciﬁc membrane raft for surface membranes or
for subcellular membranes [191], which Nef itself has the
ability to regulate by modulating the lipid composition of
the virus envelope and host cell membrane rafts through, for
example, activation of lipid kinases such as PI3K [192]. HIV-
1 release from certain cell lines is enhanced by the viral Vpu
protein, which is partitioned into membrane rafts. Trans-
membrane mutants of the Vpu protein have impaired HIV-1
particle release function due to deﬁciency of raft associa-
tion but still maintain the ability to down regulate CD4
[200]. For HIV-1 assembly and budding, membrane rafts
are also associated with cellular factors such as human
cellular cystidine deaminase APOBEC3G (hA3G), BST-2/
CD317/HM1.24 (tetherin), caveolin-1, and tetraspanins.Biochemistry Research International 11
hA3G inhibits infectivity of progeny virus particles by its
incorporation into virus particles through its association
withmembranerafts[195,201].Tetherinalsoexertsantiviral
activity against HIV-1 and other enveloped viruses as an
interferon-inducible factor of the innate immune system by
inhibition of progeny virus particle release from the cell sur-
face. Viral propagation among T cells proceeds by direct cell-
to-cell transmission through membrane raft-enriched syn-
apses colocalized with tetherin, which counteracts the viral
Vpuproteinpartitionedtomembranerafts,involvedinvirus
release [199]. HIV-1 infection enhances the expression of
caveolin-1, a major protein of membrane rafts. Although
membrane rafts have been shown to contribute to assembly
and budding processes of HIV-1, expression of caveolin-1
causesareductionofvirusproductioninmacrophages[198].
This suggests that caveolin-1 may contribute to persistent
infection in macrophages and that a caveolin-dependent
raft, caveola, is not necessarily an advantage for the HIV-1
lifecycle. A tetraspanin-enriched microdomain is a unique
type of protein-based microdomain, clearly distinct from
membrane rafts. Tetraspanins CD9, raft-associated CD55,
and raft marker GM1 are concentrated at the virus assembly
site. This recruitment and conﬁnement of CD9 are partially
dependent on cholesterol, whereas those of CD55 are com-
pletely dependent on cholesterol. HIV-1 assembly creates
specializedmicrodomains forrecruiting componentsofboth
membrane rafts and tetraspanin-enriched microdomains
[197]. As for retroviruses other than HIV, HTLV-1 assembly,
but not budding and surface traﬃcking, is also inhibited by
a decrease of Gag associations with membrane rafts by inter-
feron α-2a treatment [202].
VSV budding is known to occur at membrane micro-
domainscontainingtheviralenvelopeGglycoproteins,some
of which are 100–150nm in size and smaller than the virus
envelope (approximately 100–150nm) and others of which
extended in size to a maximum of 300–400nm from the
tip of the virus budding site [203, 204]. However, immu-
noelectron microscopy observation did not conﬁrm that
gold-labeled G protein-containing microdomains are equiv-
alent to lipid-enriched membrane rafts. Furthermore, such
microdomains of 300–400nm in size are too large for the
deﬁnition of raft microdomains of 10–200nm in size [3]. A
recent study has also shown that most G proteins of wild-
type VSV were not incorporated into membrane rafts in
infected osteoclasts [215]. Relevance of membrane rafts on
VSV infection will be settled in future studies.
7. Genome Replication, Assembly, and
Budding of Nonenveloped Viruses
The role of membrane rafts in intracellular assembly of non-
enveloped viruses has been investigated only in bluetongue
virus [216]a n dR o t a v i r u s[ 130, 217–220], belonging to the
family Reoviridae. Association of SNARE (soluble N-ethyl-
maleimide-sensitive fusion attachment protein receptor) do-
main in the bluetongue virus outer capsid VP5 with mem-
brane rafts may play an important role in its membrane
targeting and virus assembly [216]. Rotavirus replication
occurs at large inclusions (known as viroplasms) in the cell
cytoplasm, which are sites for replication of viral RNA and
assembly of double-layered particles. These particles are
transferred across the ER membrane by interactions of the
viral capsid protein VP6 with the nonstructural transmem-
brane glycoprotein NSP4, which has been characterized as
an ER intracellular receptor and a viral enterotoxin for intes-
tinal cells. During transfer across the ER, the virus acquires
a transient lipid envelope that is ﬁnally lost and replaced by
viralsurfacespike proteins,VP4andVP7.Inthisprocess,the
involvement of transient enveloped particles in membrane
rafts is highly questionable since rafts are thought to be
absent fromthe ER. Association of VP4 with membrane rafts
in the extrareticular compartment facilitates rotavirus mor-
phogenesis as a ﬁnal assembly platform and apical target-
ing toward the release process [130, 217, 218]. The raft-
type membrane microdomains associated with VP4 are
signiﬁcantly dependent on raft heterogeneity of cell lines
[219]. Moreover, N-glycosylation of NSP4 is processed in the
Golgi network through caveola-dependent Golgi network-
bypassing transport [220].
8. Role of Membrane Rafts in
Virus-InducedSignalTransductions
Viral replication eﬃciency, viral infection sites, and viral in-
fectiousdiseasesarefrequentlycontrolledbymembranerafts
in host cells and immune cells. Membrane rafts also act as
as c a ﬀold of various cellular signal transductions. Involve-
ment of membrane rafts in many viral infectious diseases
often results from up- or downregulation of cellular signal
transductions associated with cell proliferation, apoptosis,
cell diﬀerentiation, immune response, and so on.
HTLV-1 Tax1 protein recruits IκB kinases (IKKs) to
membrane rafts for persistent activation of NF-κB, which
enhances T-cell proliferation, thereby contributing to HTLV-
1-induced T-cell leukemia [221].
Flaviviruses DEN type 2 and JEV activate the raft-de-
pendent PI3K/Akt pathway that induces antiapoptosis in
order to protect infected cells from early apoptotic cell death.
However, this signaling is not essential for ﬂavivirus repli-
cation. A balance between apoptotic and antiapoptotic sig-
naling, which is triggered by the interplay between host and
virus, controls the outcome of ﬂavivirus infection [17]. DEN
NS1, which can be found in membrane rafts on the host
cellsurface,increasesNF-κBtranscriptionalactivitiesbyfaci-
litatingnucleartranslocationofNF-κBp65proteininHepG2
cells, suggesting a possible contribution to DEN pathogenic-
ity [149]. In JEV-infected microglia, the integrity of mem-
brane rafts and the activation of Src-related Ras/Raf/ERK
cascades participate in NF-κB activation and consequent
TNFα and interleukin-1 beta (IL-1β) expression. These sig-
nalactivationsandcytokineexpressionscausedbyJEVinfec-
tion may play a critical role in neuronal cell death [222].
The partitioning of measles virus F protein into high
buoyant density-membrane rafts activates an alternative
pathway of human complement independently of CD46 and
CD55, which regulate the complement activation and do
not exist in the same rafts as the F protein. Thus, measles12 Biochemistry Research International
virusinfectioninducesinﬂammatoryresponsethroughalter-
native complement activation [223]. Measles virus-induced
immunosuppression also results from signal transduction
alteration such as PI3K present in membrane rafts of T cells
[224].
HSV-1 infection is implicated in Alzheimer’s disease sus-
ceptibility by virus binding to HSPGs, nectin receptors, α2-
macrolgobulin, blood-borne lipoproteins, and apolipopro-
tein E. Cholesterol reduction on the plasma membrane by
a cholesterol synthesis inhibitor has been linked to a decrease
in the risk for development of Alzheimer’s dementia. Since
HSV-1 uptake into cells is dependent on cholesterol and
membrane rafts, cholesterol reduction may decrease the
availability of raft-dependent pathways to spread HSV-1 in
the brain [225, 226]. Tyrosine kinase-interacting protein
(Tip) of lymphotropic herpesvirus saimiri (HVS) down-
regulates T-cell receptor (TCR) and CD4 expression on the
cellsurfacethroughitstargetingtomembraneraftsinTcells.
T i pi sr e q u i r e df o rc e l l u l a rm e m b r a n ed e f o r m a t i o no fTc e l l s
but not for viral replication, which induces lymphoma in
primates [227]. HHV-8 encodes two RING ﬁnger E3 ubiq-
uitin ligases (MIR1 and MIR2) that mediate ubiquitination
and degradation of cellular proteins important for immune
response. Many of the MIR substrates are believed to be
present in membrane rafts. Function of MIR2 is required
for its palmitoylation, which is known as a posttranslational
modiﬁcation that enhances recruitment of transmembrane
proteins into membrane rafts. MIR2 function may play
an important role in immune evasion of the virus and
resultant persistent viral infection by MIR2-mediated down-
regulation of MHC-I and platelet endothelial cell adhesion
molecule 1 (PECAM-1) [228].
GM1 expression and asialo-GM1 expression in mem-
braneraftsofTcellsandnaturalkiller(NK)cellsarediﬀeren-
tially regulated by these cells in the context of RSV infection.
Asialo-GM1mayincreaseRSVclearancebyincreasingIFN-γ
levels in mouse lungs [229].
The pseudorabies virus Us9 protein interacts with mem-
brane rafts and then promotes targeting of viral structural
proteins to neuronal axons. Consequently, the virus spreads
from presynaptic to postsynaptic neurons and cells of the
mammalian nervous systems [108].
Raft-dependent phagocytosis of HCV-infected apoptotic
vesicles containing viral double-strand RNA (dsRNA) is re-
quiredformaturationofhumanmonocyte-deriveddendritic
cells (MoDCs). However, HCV JFH1 strain, which can eﬃ-
ciently replicate in cell culture, does not directly stimulate
MoDCs for activation of T cells and NK cells [230]. HCV
envelope E2 protein attenuates interleukin-2 (IL-2) produc-
tion at the level of secretion by its interaction with tetra-
spanin CD81 coreceptor and sequent recruitment of protein
kinase C beta (PKCβ), which is essential for IL-2 secretion,
to membrane rafts in peripheral blood mononuclear cells.
The ability of the E2 protein to attenuate IL-2 and IFN-γ
secretion has been suggested to contribute to a mechanism
for HCV to evade the human immune response and to
establish persistent infection [231].
Antibodies against SARS-CoV spike domain2 (S2) in pa-
tient sera can cross-react with human lung epithelial cells
through annexin A2, which has been identiﬁed as one of the
candidate proteins of the autoantigen. SARS-CoV-induced
cytokines interlekin-6 (IL-6) and INFγ stimulate surface ex-
pression and raft distribution of annexin A2 in human lung
type II epithelial A549 cells and increase the binding capabil-
ity of anti-S2 antibodies to human lung epithelial cells. The
upregulated expression and raft targeting of annexin A2 and
the cross-reactivity of anti-S2 antibodies to annexin A2 may
contribute to the pathogenesis of SARS disease [232].
Rhinovirus serotype 39 colocalizes with Src kinases,
PI3K, and the serine threonine kinase Akt in membrane rafts
in the context of virus infection. Src and PI3K are upstream
activators of Akt and the interleukin-8 (IL-8) promoter.
Rhinovirus infection activates these kinases and sequent IL-8
expression, which exacerbates asthma and chronic obstruc-
tive pulmonary disease [233].
PersistentHPVinfectionresultsintransformationofepi-
thelial cells that induces cellular polarity disturbance, which
is implicated in MAL and BENE, components of the mem-
brane raft’s machinery for apical sorting of membrane pro-
teins. Down-regulation of MAL and BENE genes in the con-
text of HPV infection may play an important role in devel-
opment of human cervical squamous cell cancer [112]. The
“early” gene oncoproteins E6 and E7 of high-risk HPV are
known to be invariably expressed in cervical cancers by
inducing several signal alterations such as p53 inactivation,
apoptosis suppression, telomerase activation, and cell adhe-
sion disruption [234]. The additional oncoprotein E5 of
high-risk HPV type 16 increases expression and association
of both GM1 and caveolin-1, components of membrane
rafts, on the cell surface. This up-regulation of membrane
rafts helps HPV immune evasion by suppression of cytotoxic
T lymphocytes and enhances proliferative signaling of epi-
dermal growth factor (EGF) possibly through localization of
the EGF receptor with membrane rafts [235].
9. Role of Membrane Rafts in Prion Infection
Involvement of membrane rafts in infectious particle prion
(PrP) infection has been reported [236–242]. PrP is an
infectious protein that does not have a genome, unlike
viruses. PrPSc, the protease-resistant isoform of the host nor-
mal prion protein PrPc, is the infectious component causing
fetal neurodegenerative transmissible spongiform encepha-
lopathies, called Creutzfeldt-Jakob disease in humans. PrPc,
which contains a conserved N-terminal cationic domain that
stimulates a raft-dependent pathway, internalizes in neurob-
lastoma N2a cells through a clathrin-independent pathway
associatedwithArf6[241]andraft-dependentmacropinocy-
tosis [240]. On the other hand, PrPc internalizes in Fischer
rat thyroid (FRT) cells by cooperation of clathrin-dependent
and raft-dependent pathways. This internalization does not
aﬀect caveolin expression in FRT cells, which do not express
caveolin-1anddonothaveanycaveolae.Theseﬁndingsindi-
cate that pathways of PrPc internalization are dependent on
cell type and that the raft-dependent pathway distinctly dif-
fers from the caveola-dependent pathway [242]. Association
of PrPC with cholesterol-enriched membrane rafts enhances
correct protein folding of PrPc conformation. CholesterolBiochemistry Research International 13
Table 1: Function of membrane rafts in enveloped DNA viruses.
Family Virus Process
Epstein-Barr virus
(EBV) Entry
Herpes simplex virus-1
(HSV-1)
Entry
Assembly
Progeny virus
infectivity
Alzheimer’s disease
susceptibility
Porcine herpesvirus-1
(pseudorabies virus)
Entry
Viral spread in neurons
Herpesviridae Human herpesvirus-6
(HHV-6)
Entry
Assembly
Human herpesvirus-8
(HHV-8)
Entry
Viral immune evasion
Persistent infection
Murine
cytomegalovirus
(MCMV)
Assembly
Lymphotropic
herpesvirus saimiri
(HVS)
Lymphoma
Poxviridae Vaccinia virus Entry
Penetration
depletion, but not sphingolipid depletion, leads to abnormal
protein folding from PrPc to PrPSc [236–238]. GPI-anchored
HSPG glypican-1 directly interacts with both PrPc and PrPSc
andtargetsthesetomembranerafts.Targetingofbothprions
through glypican-1 facilitates favorable interaction of PrPSc
with PrPc within membrane rafts, which are believed to be
the conversion sites of PrPc to PrPSc,s u g g e s t i n gac r i t i c a lr o l e
of glypican-1 in the pathogenesis of prion disease [243]. PrPc
is associated with membrane rafts in membrane-derived mi-
crovesicles of human plasma that are important modula-
tors of cell-to-cell communication. Membrane-derived mic-
rovesicles bearing PrPc within membrane rafts may contri-
bute to intercellular diﬀusion, intracellular signaling, and
neuroinvasion of PrPc [244]. The property of the GPI anchor
attached to PrPSc has been reported to aﬀect the bind-
ing of PrPSc to neurons, distribution to membrane rafts, and
conversion of endogenous PrPc in GT1 neuronal cells [245].
Moreover, the increased level of glycosphingolipid GM1 (an
essential raft marker) on ﬁbroblast cells by a mouse par-
vovirus (Parvoviridae) infection may promote prion infec-
tion through the incorporation of exogenous PrPSc into
membrane rafts [239].
10. Conclusion
Many studies have suggested the involvement of membrane
rafts in cell entry, genome replication, assembly, budding,
and virus-associated diseases of enveloped and nonenvelo-
p e dv i r u s e s( s u m m a r i z e di nT a b l e s1, 2, 3,a n d4). Paradoxi-
cally, some recent studies have shown that membrane rafts
are not necessarily required for eﬃcient viral replication.
For the virus entry process, many viruses use several dif-
Table 2: Function of membrane rafts in enveloped RNA viruses.
Family Virus Process
Arenaviridae
Lymphocytic
choriomenin-
gitis virus
(LCMV)
Entry
Coronaviridae SARS-CoV,
coronavirus
Entry
Lung pathogenicity
Filoviridae Ebola virus
Entry
Fusion
Assembly
Budding
Marburg virus Entry
Budding
Flaviviridae
Dengue virus
(DEN)
Entry
Viral RNA replication
ADE of viral infection
Antiapoptosis
Pathogenicity
Japanese
encephalitis
virus
(JEV)
Entry
Viral RNA replication
Progeny virus
production
Anti-apoptosis
Neuronal pathogenicity
West Nile virus
(WNV)
Entry
Basolateral
transportation
in endothelial cells
Viral spreads from the
blood
stream to the central
nervous
system and peripheral
tissues
Human
hepatitis C
virus
(HCV)
Entry
Vrial RNA replication
Progeny virus infectivity
Budding
MoDC maturation
Viral immune evasion
Persistent infection
Orthomyxoviridae Inﬂuenza virus
Fusion
Assembly
Budding
Progeny virus infectivity
Apical targeting
Viral proton channel
Paramyxoviridae
Measles virus
Assembly
Inﬂammatory response
Immunosuppression
Newcastle
disease virus
(NDV)
Assembly
Budding
Progeny virus infectivity
Respiratory
syncytial virus
(RSV)
Viral RNA replication
Assembly
Budding
Host immune response14 Biochemistry Research International
Table 2: Continued.
Family Virus Process
Sendai virus Assembly
Retroviridae
Human
immunodeﬁ-
ciency virus
(HIV)
Entry
Assembly
Budding
Release
Progeny virus
production
Viral nephropathy
Persistent infection in
macrophages
Human T
lymphotropic
virus 1
(HTLV-1)
Entry
Fusion
Assembly
Tc e l ll e u k e m i a
Rhabdoviridae
Vesicular
stomatitis
virus
(VSV)
Budding
Togaviridae
Semliki forest
virus
Sindbis virus
Fusion
Entry
Table 3: Function of membrane rafts in nonenveloped DNA viru-
ses.
Family Virus Process
Adenoviridae
Species C human
adenovirus
(HAdV)
Entry
Papovaviridae
Simian virus 40
(SV40) Entry
BK virus Entry
JC virus Entry
Bovine papillomavirus Entry
Human papillomavirus Entry
(HPV)
Immune evasion
Persistent infection
Cancer development
Parvoviridae Mouse parvovirus Prion infection
ferent pathways, not only caveola/raft-dependent but also
clathrin-dependent or another endocytic pathway such as
macropinocytosis.Additionally,thecaveola-dependentpath-
way does not necessarily correspond to the raft-dependent
one, suggesting the existence of other complicated pathways
associated with caveolae and membrane rafts. For the
assembly and budding processes of many enveloped viruses,
membrane raft disruption on host cells facilitates formation
andproductionofprogenyvirusparticleswithlessinfectivity
and lower viral components. Also, membrane rafts are not
necessarily essential for cellular membrane targeting of viral
structural proteins. For virus assembly and budding, mem-
brane rafts are more likely to provide progeny virus particles
with greater infectivity because of the concentration and
Table 4: Function of membrane rafts in nonenveloped RNA viru-
ses.
Family Virus Process
Picornaviridae
Echovirus
types 1 and 11 Entry
Enterovirus Entry
Rhinovirus Entry
Cellular kinase activation
Coxsackie virus
A9, B3 and B4 Entry
Reoviridae Rotavirus
Entry
Assembly
Apical targeting
Golgi transport
Bluetongue virus
Entry
Assembly
Membrane targeting
eﬃcient incorporation of viral structural components from
the assembly and budding sites to the virus particles. Simi-
larly,concentrationofviralpolymerasesintomembranerafts
acts as a platform of more eﬃcient replication and trans-
cription of viral genomes. Furthermore, the use of several
endocytic pathways provides an advantage for virus entry
into a wider range of hosts, cell lines, and tissues or can
allow the virus to be assigned to an alternative pathway
when one pathway does not work. Concentration of viral
fusion proteins in raft-associated receptors or caveola/raft-
dependent endocytosis may enhance membrane fusion bet-
ween the virus and cell, leading to eﬃc i e n tr e l e a s eo fvi r a li n -
ternal proteins and genomes to the cytoplasm at an early
stage of virus infection. Taken together, the results indicate
that membrane rafts are not essential for viral life cycles.
Viruses probably take advantage of membrane rafts for more
eﬃciency of virus entry, viral genome replication, and virus
particle production. Viruses also induce many raft-mediated
cellularsignalswhichrelatetocharacteristicsymptomsofthe
viral diseases.
Many studies on the involvement of membrane rafts in
viral infection cycles and viral infectious diseases have been
performed by classical approaches (cholesterol-disrupting
reagent treatments, detergent-insoluble fractionization, and
microscopic observation of colocalization with raft markers)
and by recent molecular biological approaches (RNAi and
dominant negative expression against representative raft
components). However, since various types of microdo-
mains, such as raft-dependent, caveola-dependent, choles-
terol-dependent, and other specialized microdomains, have
been shown to have independent heterogeneous properties,
evaluation of respective functions of distinct membrane
rafts and microdomains would be diﬃcult by experiments
using only common approaches to study membrane rafts.
Further study will require new approaches for elucidating
the functions of distinct membrane microdomains. An un-
derstanding of the role of membrane rafts in viral lifecycle
may contribute to elucidation of essential cellular functionsBiochemistry Research International 15
of membrane rafts and to development of new antiviral
chemotherapy against viral replications and viral infectious
diseases.
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